Credit Suisse Group has priced the issuance of USD 1.65 bn 9.750 per cent. Perpetual Tier 1 Contingent Write-down Capital Notes. The Notes are «high trigger» regulatory capital instruments that are eligible to fulfill
Tags :Benjamin Leisinger
Julius Baer Group has placed a perpetual non-cumulative Additional Tier 1 (AT1) securities in a USD 400 million transaction with private banks and institutional investors in Asia and Europe. The transaction will help to optimise Julius Baer
HIAG Immobilien Holding has placed a fixed-interest bond on the Swiss capital market in the amount of CHF 150 million with a coupon of 1.77% and a term of 4 years and 5 months, maturing as of 30 October 2026. The
Credit Suisse has successfully completed its issuance of €1 billion aggregate principal amount of 2.125% senior notes due 2024 and €750 million aggregate principal amount of floating rate senior notes due 2024. The bonds were issued under Credit Suisse’s
Zürcher Kantonalbank has completed its issuance of EUR 500 million 2.020 per cent. Fixed-to-Floating Rate Tier 2 Bonds due 2028. The Bonds are regulatory capital instruments that are eligible to fulfill Zürcher Kantonalbank’s Swiss gone concern
On April 7, 2022, Credit Suisse completed its registered offering of USD 2.5 billion aggregate principal amount of senior notes. The offering consisted of USD 2.1 billion aggregate principal amount of 3.700% senior notes due 2025 and USD 400 million aggregate principal
On March 24, 2022, Credit Suisse Group successfully completed its issuance of (i) EUR 2 bn aggregate principal amount of 2.125 per cent. Fixed Rate Reset Senior Callable Notes due 2026 and (ii) EUR 1.5 bn aggregate principal amount of 2.875 per
On December 12, 2021, January 12, and January 20, 2022, respectively, 21Shares, a Zug-based special purpose issuance vehicle of the fintech group Amun for crypto-linked exchange traded products (ETPs), successfully issued and listed three new series of crypto-linked ETPs on
Berner Kantonalbank has successfully completed the placement of CHF 200 m 0.85 per cent. Tier 2 bonds. Zürcher Kantonalbank acted as Structuring Advisor and Lead Manager and Berner Kantonalbank acted as Co-Manager. The bonds will be listed
CSL Limited, a global biotechnology company based in Australia and Vifor Pharma, a Swiss-based global pharmaceutical company, entered into an agreement for CSL to launch an all-cash public tender offer to acquire all publicly held
